Description

Riboxin-Darnitsa (inosine) ampoules 20 mg/ml 10 ml. №10

Ingredients:

Each ampoule contains: inosine 20 mg/ml.

Dosage:

The usual dose is: 1-2 ampoules per day, administered intravenously or intramuscularly.

Indications:

Riboxin-Darnitsa is indicated for: improving myocardial metabolism, treating coronary heart disease, and supporting liver function.

Contraindications:

Do not use Riboxin-Darnitsa if you have: hypersensitivity to inosine, acute gout, or hyperuricemia.

Directions:

Administer as directed by a healthcare professional. The solution should be clear and free from particles before use.

Scientific Evidence:

Studies have shown that inosine, the active ingredient in Riboxin-Darnitsa, plays a crucial role in cellular energy metabolism. It has been demonstrated to improve ATP production in cardiac cells, which can enhance myocardial function and overall cardiovascular health.

Furthermore, clinical trials have indicated that inosine supplementation may have a protective effect on the liver by promoting regeneration of hepatocytes and improving liver function markers in patients with liver diseases.

Additional Information:

It is important to note that Riboxin-Darnitsa should be used under medical supervision, especially in patients with pre-existing medical conditions or those taking other medications. Consult a healthcare provider before starting any new treatment regimen.

Overall, Riboxin-Darnitsa offers a promising therapeutic option for conditions related to impaired energy metabolism and organ dysfunction. Its mechanism of action and clinical benefits make it a valuable addition to the treatment armamentarium in cardiology and hepatology.